parkinson - Search News

Ozzy Osbourne Can No Longer Walk Due to Parkinson’s Disease

Hosted on MSN · 1h

Ozzy Osbourne's Parkinson's disease 'affected his legs,' Sharon says as his last show looms

Heavy metal star Ozzy Osbourne reveals the date for his final show, which will also reunite the founding members of Black Sabbath after 20 years.

People on MSN · 1d

Ozzy Osbourne Can No Longer Walk Due to Parkinson’s Ahead of Final Show with Black Sabbath

Sharon Osbourne gave an update on how Parkinson’s disease has impacted husband Ozzy Osbourne’s legs as the musician prepares to reunite with Black Sabbath in July for his final concert.

Newsweek on MSN · 1d

Ozzy Osbourne to Hit the Stage With Black Sabbath Amid Debilitating Parkinson's Battle

Black Sabbath will be reuniting for a performance in Ozzy Osbourne's hometown of Birmingham, U.K.. Osbourne, 76, has been battling Parkinson's disease for years, but the Prince of Darkness will not let that keep him from the stage.

Daniel Barenboim, Parkinson's disease

The New York Times · 1d

Daniel Barenboim Announces He Has Parkinson’s Disease

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, said Thursday that he has Parkinson’s disease.

The Washington Post · 1d

Conductor Daniel Barenboim says he's been diagnosed with Parkinson's disease

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday on Instagram. He has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner’s Ring Cycle in Berlin.

BBC on MSN · 1d

Conductor Barenboim reveals Parkinson's diagnosis

The renowned musician says he plans to keep playing, after confirming the long-suspected diagnosis.

4h

Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

MedPage Today23h

Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial?

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

2d

Drug Similar to Ozempic Failed to Treat Parkinson’s Disease in a Trial

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

1don MSN

She was diagnosed with Parkinson’s at 27. These were her warning signs.

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

Psychology Today1d

A Suggested Revolution in Parkinson’s Research

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

2d

Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

Despite Early Promise GLP-1 Disappoints in Parkinson’s Disease

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...

Wales Online20h

Phil Parkinson's brutally honest chat before announcing blockbuster Wrexham transfer

Ben Foster has revealed the brutally honest chat he had with Phil Parkinson before sensationally joining Wrexham for a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results